ITMCTR2200005712尚未招募1 期
Yiqi Chupi Powder for treating chemotherapy-related fatigue after colorectal cancer surgery:a multicenter randomized controlled trial
Shanxi Province Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 80(—)
- 性别
- All
入选标准
- •1.The pathological examination conforms to the diagnostic criteria of western medicine for colorectal cancer;
- •2.Postoperative stage of colorectal cancer is stage II with high-risk factors; or postoperative stage is stage III and requires postoperative adjuvant chemotherapy.
- •3.Comply with the diagnostic criteria of TCM syndrome of qi deficiency and kidney deficiency;
- •4.Age between 18-80 years old, no gender restrictions;
- •5.Liver and kidney function and hematopoietic function are basically normal(in the absence of ongoing supportive care):Neutrophils>1.5×109/L, platelets>100×109/L, hemoglobin>9.0g/dL; total bilirubin normal or <1.5×ULN; AST(SGOT), ALT(SGPT) <2.5×ULN ; Serum creatinine <1.5×ULN;
- •6.Expected survival = 6 months;
- •7.The score of KPS=60 points;
- •8.Signing the informed consent voluntarily .
排除标准
- •1.Patients who have mental disorders (mental disorders or severe dementia);
- •2.Liver and kidney functions are abnormal(AST, ALT, TBIL values are higher than 2.5 times the upper limit of normal values or BUN, Cr values are higher than 2 times the upper limit of normal values), Cardiac enzyme abnormalities(CK or CK-MB values above the upper limit of normal); Blood routine is abnormal(WBC, HGB, PLT are lower than the normal);
- •3.The patients who combined with other serious circulatory system, hematopoietic system, digestive system, endocrine system and other diseases;
- •4.Those who refuse postoperative adjuvant chemotherapy;
- •5.Pregnant, breastfeeding and planning to become pregnant;
- •6.He people participated in other clinical research in the past 1 month.
研究者
相似试验
招募中
1 期
Shiwei Yiyuan granules for treatment of cancer-related fatigue after chemotherapy in advanced cancer: a randomized double-blind controlled studyITMCTR1900002714Xiyuan Hospital CACMS
已完成
4 期
Zhengyuan Capsule in the treatment of chemotherapy-related cancer-related fatigue in patients with unresectable stage IIIB-IV non-small cell lung cancer--a multicenter, randomized, double-blind, parallel, placebo-controlled clinical trialCancer-related fatigueITMCTR2000004062The First Affiliated Hospital of Guangzhou University of Chinese Medicine
尚未招募
4 期
Yiqi Yangyin Jiedu decoction combined with chemotherapy in the treatment of advanced lung adenocarcinoma with EGFR sensitive mutation after TKI resistance: a randomized controlled double-blind studyITMCTR2000003622Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
尚未招募
不适用
Chinese Medicine Prevention and Treatment Program for Pre-clinical Rheumatoid Arthritis: An Evidence-based Evaluation StudyRheumatoid ArthritisITMCTR1900002430Zhejiang Chinese Medical University
招募中
1 期
Qingjin Yiqi Granules for patients in pneumonia recovery phase (COVID-19, Omicron): a clinical studyITMCTR2200005627Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
